AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard L. Ernst who wrote (629)	2/22/1998 5:53:00 PM
From: jpbrody	Read Replies (1) of 1728

BD, AFFX, & Nanogen. I don't know that Becton Dickson has any interest in AFFX. The big company behind the picture is Glaxo Wellcom. When Affymetrix was spun off from Affymax, I think Affymax retained like 30% of the company. Glaxo later bought Affymax outright, so they now own 30% (or so) of AFFX. Also, I just found out that Nanogen has filed an S-1. Presumably they will have an IPO soon. According to the S-1, Becton Dickinson will invest $6 million at the IPO price. (Hoechst will invest $10 million and Elan is in for $5 million.) (See edgar.sec.gov for Nanogen's S-1. It's long.) Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next